Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls

scientific article

Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1507/ENDOCRJ.EJ13-0423
P698PubMed publication ID24189751

P50authorDouglas HeimarkQ57219368
P2093author name stringJoseph Larner
Jan McAllister
P433issue2
P921main subjectpreproinsulinQ7240673
P304page(s)111-117
P577publication date2013-11-02
P1433published inEndocrine JournalQ5376304
P1476titleDecreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls
P478volume61

Reverse relations

cites work (P2860)
Q37132257A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women.
Q64069063Association between Polymorphisms of and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
Q91637037Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome
Q34546109Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients
Q47396316Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?
Q28073603Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
Q36385353Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes
Q28077261Inositol Treatment and ART Outcomes in Women with PCOS
Q92062600Inositol Treatment for PCOS Should Be Science-Based and Not Arbitrary
Q92481688Inositol and antioxidant supplementation: Safety and efficacy in pregnancy
Q38946449Inositol and human reproduction. From cellular metabolism to clinical use.
Q60947914Inositols in Insulin Signaling and Glucose Metabolism
Q28077870Inositols in the Treatment of Insulin-Mediated Diseases
Q53772354Inositols: from physiology to rational therapy in gynecological clinical practice.
Q28072521Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk
Q64058719Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
Q36152232Myo-Inositol Safety in Pregnancy: From Preimplantation Development to Newborn Animals.
Q42635246Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
Q50229339Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: a dual approach study
Q37579255Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome
Q38879505Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease
Q33775146Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
Q38513382Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology--assisted reproduction technology
Q37292119The inositols and polycystic ovary syndrome
Q38231822The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome
Q37302359Topological analysis of metabolic networks integrating co-segregating transcriptomes and metabolomes in type 2 diabetic rat congenic series
Q38217670Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome

Search more.